| Primary |
| Atrial Fibrillation |
12.9% |
| Rheumatoid Arthritis |
10.0% |
| Type 2 Diabetes Mellitus |
10.0% |
| Renal Failure Chronic |
8.6% |
| Acute Myocardial Infarction |
5.7% |
| Prophylaxis Against Gastrointestinal Ulcer |
5.7% |
| Cardiac Failure |
4.3% |
| Heart Valve Operation |
4.3% |
| Hyperlipidaemia |
4.3% |
| Hypersensitivity |
4.3% |
| Hypertension |
4.3% |
| Hypothyroidism |
4.3% |
| Pain |
4.3% |
| Pulmonary Embolism |
4.3% |
| Cerebrovascular Accident |
2.9% |
| Chronic Obstructive Pulmonary Disease |
2.9% |
| Pulmonary Arterial Hypertension |
2.9% |
| Cardiomyopathy |
1.4% |
| Coronary Artery Disease |
1.4% |
| Hyperuricaemia |
1.4% |
|
| Gastrointestinal Haemorrhage |
45.5% |
| Gingival Bleeding |
27.3% |
| Brain Stem Haemorrhage |
9.1% |
| Duodenitis Haemorrhagic |
9.1% |
| Thrombocytopenia |
9.1% |
|
| Secondary |
| Hypertension |
26.7% |
| Atrial Fibrillation |
12.2% |
| Coronary Artery Disease |
6.2% |
| Tachyarrhythmia |
6.2% |
| Rheumatoid Arthritis |
5.9% |
| Glomerulonephritis Membranous |
5.5% |
| Hyperlipidaemia |
4.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
4.4% |
| Cardiac Failure |
3.6% |
| Osteoporosis |
3.1% |
| Pulmonary Embolism |
2.6% |
| Pain |
2.5% |
| Product Used For Unknown Indication |
2.4% |
| Thrombosis Prophylaxis |
2.3% |
| Restlessness |
2.0% |
| Diabetes Mellitus |
1.9% |
| Immunosuppressant Drug Therapy |
1.9% |
| Iron Deficiency |
1.9% |
| Systemic Lupus Erythematosus |
1.9% |
| Deep Vein Thrombosis |
1.8% |
|
| Fallot's Tetralogy |
12.6% |
| Transaminases Increased |
11.6% |
| Gastrointestinal Haemorrhage |
8.4% |
| Liver Disorder |
8.4% |
| Pancreatitis Acute |
6.3% |
| Hepatitis Toxic |
4.2% |
| Hyperglycaemia |
4.2% |
| Hypertensive Crisis |
4.2% |
| Oesophagitis Haemorrhagic |
4.2% |
| Pulmonary Embolism |
4.2% |
| Vomiting |
4.2% |
| Haematuria |
3.2% |
| Hyperkalaemia |
3.2% |
| Hypertransaminasaemia |
3.2% |
| Hypocoagulable State |
3.2% |
| International Normalised Ratio Increased |
3.2% |
| Maternal Exposure During Pregnancy |
3.2% |
| Prothrombin Time Prolonged |
3.2% |
| Syncope |
3.2% |
| Bradycardia |
2.1% |
|
| Concomitant |
| Hypertension |
21.8% |
| Product Used For Unknown Indication |
20.1% |
| Rheumatoid Arthritis |
11.0% |
| Atrial Fibrillation |
6.5% |
| Pain |
5.5% |
| Cardiac Failure |
4.9% |
| Drug Use For Unknown Indication |
3.8% |
| Chronic Obstructive Pulmonary Disease |
3.6% |
| Coronary Artery Disease |
3.2% |
| Osteoporosis |
2.9% |
| Diabetes Mellitus |
2.5% |
| Thrombosis Prophylaxis |
2.1% |
| Tachyarrhythmia |
2.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.8% |
| Prophylaxis |
1.6% |
| Hyperuricaemia |
1.6% |
| Hypercholesterolaemia |
1.3% |
| Type 2 Diabetes Mellitus |
1.3% |
| Pulmonary Embolism |
1.2% |
| Depression |
1.1% |
|
| Drug Interaction |
14.5% |
| Renal Failure Acute |
9.7% |
| Vomiting |
7.3% |
| General Physical Health Deterioration |
6.7% |
| Clostridium Difficile Colitis |
5.5% |
| Dehydration |
4.8% |
| Syncope |
4.8% |
| Tubulointerstitial Nephritis |
4.8% |
| Urinary Tract Infection |
4.8% |
| Colitis |
4.2% |
| Faecaloma |
4.2% |
| Weight Increased |
4.2% |
| Hypotension |
3.6% |
| Coronary Artery Disease |
3.0% |
| Pericardial Haemorrhage |
3.0% |
| Pneumonia |
3.0% |
| Tibia Fracture |
3.0% |
| Transaminases Increased |
3.0% |
| Weight Decreased |
3.0% |
| Cardiac Failure |
2.4% |
|
| Interacting |
| Hypertension |
17.2% |
| Aortic Surgery |
8.6% |
| Cardiac Failure |
8.6% |
| Congestive Cardiomyopathy |
8.6% |
| Tachyarrhythmia |
8.6% |
| Rheumatoid Arthritis |
7.8% |
| Atrial Fibrillation |
6.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
6.0% |
| Hyperlipidaemia |
3.4% |
| Mycosis Fungoides |
3.4% |
| Immunosuppressant Drug Therapy |
2.6% |
| Iron Deficiency |
2.6% |
| Osteoporosis |
2.6% |
| Pulmonary Arterial Hypertension |
2.6% |
| Restlessness |
2.6% |
| Atrial Flutter |
1.7% |
| Back Pain |
1.7% |
| Coronary Artery Disease |
1.7% |
| Gout |
1.7% |
| Ischaemic Heart Disease Prophylaxis |
1.7% |
|
| International Normalised Ratio Increased |
25.0% |
| Transaminases Increased |
18.8% |
| Drug Interaction |
12.5% |
| Hyperthyroidism |
12.5% |
| Rectal Ulcer Haemorrhage |
12.5% |
| Gastrointestinal Haemorrhage |
6.3% |
| Haemorrhage |
6.3% |
| Haemorrhage Intracranial |
6.3% |
|
